Mediterranean leishmaniasis in HIV-infected patients: Epidemiological, clinical, and diagnostic features of 22 cases

被引:32
作者
Agostoni, C
Dorigoni, N
Malfitano, A
Caggese, L
Marchetti, G
Corona, S
Gatti, S
Scaglia, M
机构
[1] Univ IRCCS San Matteo, Infect Dis Res Labs, Parasitol Lab, I-27100 Pavia, Italy
[2] IRCCS, Policlin San Matteo, Parasitol Lab, Virol Serv, Pavia, Italy
[3] IRCCS, Policlin San Matteo, Div Infect & Trop Dis, Pavia, Italy
[4] Trento Hosp, Div Infect Dis, Trento, Italy
[5] Ca Granda Niguarda Hosp, Div Infect Dis, Milan, Italy
[6] Gen Hosp, Div Infect Dis, Busto Arsizio, Italy
关键词
D O I
10.1007/BF02767767
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Twenty-two Italian HIV-infected patients developed leishmaniasis, clinically manifested as visceral (13 cases), cutaneous (2 cases) and disseminated disease (7 cases), Twenty were males and two females (mean age: 32.8 years) with a mean CD4+ cell count of 46.8/mu l at diagnosis; risk factors were intravenous drug use (17 patients) and sexual behaviour (two bisexual, two homosexual, one heterosexual). All but one patient lived or travelled in hypoendemic Italian regions and other Mediterranean countries, Apart from the two patients with cutaneous leishmaniasis, the clinico-pathological and biological spectrum of the infection was often atypical, especially in patients with disseminated disease. The diagnosis was routinely made by direct recovery of parasites in biological specimens, mainly in bone marrow aspirate, whereas serology was negative or borderline in most of the patients. Among 17 in vitro isolates, Leishmania infantum was the only species involved with previously undescribed isoenzyme patterns in two cases. Treatment with antimonials and other drugs showed only temporary clinical improvement in some patients, Relapses were the rule. Leishmaniasis confirms itself as an opportunistic infection in HIV-positive persons, Secondary chemoprophylaxis should be considered in cases of relapsing disease.
引用
收藏
页码:93 / 99
页数:7
相关论文
共 25 条
[1]   LEISHMANIASIS AND AIDS COINFECTION - THE SPANISH EXAMPLE [J].
ALVAR, J .
PARASITOLOGY TODAY, 1994, 10 (04) :160-163
[2]   Leishmania and human immunodeficiency virus coinfection: The first 10 years [J].
Alvar, J ;
Canavate, C ;
GutierrezSolar, B ;
Jimenez, M ;
Laguna, F ;
LopezVelez, R ;
Molina, R ;
Moreno, J .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (02) :298-+
[3]   Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients [J].
Amela, C ;
LopezGay, D ;
Alberdi, JC ;
Castilla, J .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1996, 12 (01) :91-92
[4]   Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years [J].
Berman, JD .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (04) :684-703
[5]   ASYMPTOMATIC LEISHMANIASIS IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) [J].
CONDOM, MJ ;
CLOTET, B ;
SIRERA, G ;
MILLA, F ;
FOZ, M .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (09) :767-768
[6]   Diagnosis of visceral leishmaniasis in HIV-infected patients [J].
Gasser, I ;
Jaen, A ;
Gonzalez, J ;
Ribera, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (12) :967-968
[7]  
GRADONI L, 1995, B WORLD HEALTH ORGAN, V73, P191
[8]   Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy [J].
Gradoni, L ;
Scalone, A ;
Gramiccia, M ;
Troiani, M .
AIDS, 1996, 10 (07) :785-791
[9]   HIV-LEISHMANIA COINFECTIONS IN ITALY - ISOENZYME CHARACTERIZATION OF LEISHMANIA CAUSING VISCERAL LEISHMANIASIS IN HIV PATIENTS [J].
GRAMICCIA, M ;
GRADONI, L ;
TROIANI, M .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1992, 86 (02) :161-163
[10]  
Herrera E, 1996, EUR J DERMATOL, V6, P501